BIOPHARMA CREDIT PLC BOPCF
COM · Closed-End Fund · CUSIP G12808104
1
institutional holders
+0 vs Q3 2022
1.8m
shares reported held*
$1.7mreported value*
0 new
1 added
0 reduced
0 sold out
net bought ≈ $746.7k (+782.2k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.95.
Trends to Q4 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 1 |
| Q4 2022 | 1 |
Biggest buyers
| Aubrey Capital Management Ltd | Added | +782.2k |
Biggest sellers
| None |
Holders, Q4 2022
| Manager | Shares | Change |
|---|---|---|
| Aubrey Capital Management Ltd 1.40% of their portfolio | 1.8m $1.7m | Added +782.2k |